Загрузка...
Rituximab in the treatment of autoimmune haemolytic anaemia
Rituximab is a B-cell depleting monoclonal antibody that is gaining popularity as an effective therapy for many autoimmune cytopenias. This article systematically evaluates its therapeutic efficacy in the treatment of different types of autoimmune haemolytic anaemia. We conclude that there is suffic...
Сохранить в:
| Опубликовано в: : | Br J Clin Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BlackWell Publishing Ltd
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415708/ https://ncbi.nlm.nih.gov/pubmed/25139610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12498 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|